Taking ibuprofen and baclofen together is not strictly prohibited, and the two are commonly prescribed alongside each other for conditions like low back pain. But the combination carries a real and underappreciated risk: ibuprofen can impair kidney function enough to slow the body’s ability to clear baclofen, potentially allowing the muscle relaxant to build up to toxic levels. Understanding how these two drugs interact, who is most vulnerable, and what the research actually says about the combination’s usefulness matters if you or your doctor are considering it.
Why These Two Drugs End Up Together
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that reduces pain and swelling. Baclofen is a muscle relaxant that acts on the nervous system to ease muscle spasms and stiffness. The logic behind combining them is straightforward: one targets inflammation, the other targets the muscle tightness that often accompanies it. For acute low back pain in particular, doctors have long paired NSAIDs with muscle relaxants to cover both sides of the problem.
This pairing is remarkably common. In U.S. prescribing data, NSAIDs and muscle relaxants are among the most frequently written prescriptions for back pain, with traditional NSAIDs alone accounting for about 16% of all back pain prescriptions and muscle relaxants close to 19%.1PubMed. Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States Among individual NSAIDs, ibuprofen and naproxen make up the majority of prescriptions, so the chances of these two drugs landing on the same patient’s nightstand are substantial.
How Ibuprofen Can Raise Baclofen Levels in the Body
The interaction between ibuprofen and baclofen centers on the kidneys. Baclofen is unusual among commonly prescribed drugs in that the body does not break it down extensively through the liver. Instead, roughly 70% of a baclofen dose is excreted unchanged by the kidneys, with glomerular filtration (the kidney’s basic filtering mechanism) serving as the primary route of removal.2PubMed. Plasma and urinary excretion kinetics of oral baclofen in healthy subjects This means baclofen levels in your blood are closely tied to how well your kidneys are working at any given moment.
Ibuprofen, like other NSAIDs, works by blocking enzymes called COX-1 and COX-2.3PubMed Central. Nonsteroidal Anti-Inflammatory Drugs and the Kidney These enzymes do more than just produce inflammation and pain signals. In the kidneys, they help maintain blood flow to the filtering structures. When ibuprofen suppresses that process, kidney filtration can temporarily slow down, especially in people who are older, dehydrated, or already have some degree of kidney compromise. The result: baclofen that would normally be cleared efficiently starts accumulating, and blood levels climb higher than intended.
This is not a theoretical concern. A well-documented case from the clinical literature describes a patient whose kidney function markers rose sharply after starting ibuprofen 600 mg three times daily. Blood urea nitrogen climbed from 13 to 59 mg%, and serum creatinine went from 0.9 to 2.8 mg%. With the kidneys no longer clearing baclofen properly, the patient developed confusion, disorientation, a dangerously slow heart rate, and hypothermia, all hallmarks of baclofen toxicity.4PubMed. Baclofen toxicity associated with declining renal clearance after ibuprofen
Reported Cases of Toxicity
The kidney-mediated interaction is not limited to people with pre-existing kidney problems. A case report published in Cureus described encephalopathy (a broad term for brain dysfunction causing altered mental status) in an otherwise healthy young adult who was taking both ibuprofen and baclofen concurrently. The baclofen dose was low, yet the patient still developed significant neurological symptoms.5PubMed Central. Low-Dose Baclofen-Induced Encephalopathy in a Healthy Young Adult: Is Baclofen Toxicity Dose-Dependent? The authors specifically highlighted the potential drug interaction as a contributing factor and emphasized the need for patient education when baclofen is started.
What makes this case striking is the “healthy young adult” part. The assumption many people carry, that drug interactions mostly threaten elderly or medically fragile patients, does not hold cleanly here. Even modest ibuprofen-driven reductions in kidney filtration may be enough to push baclofen levels into a dangerous range in someone who would otherwise seem low-risk. The case underscores that the interaction is not dose-dependent in a simple linear way; individual variation in kidney sensitivity to NSAIDs can make the outcome unpredictable.
Does Adding Baclofen to Ibuprofen Actually Help for Back Pain?
Given that the combination carries a documented interaction risk, you would hope the payoff in terms of pain relief would be substantial. The evidence says otherwise. A randomized trial of 320 patients with acute low back pain tested ibuprofen paired with one of three muscle relaxants (baclofen, metaxalone, or tizanidine) against ibuprofen paired with a placebo. After one week, the groups were essentially indistinguishable. Patients who got ibuprofen plus baclofen improved by about 10.6 points on a standard disability questionnaire, compared to 11.1 points for the group that got ibuprofen plus a placebo pill. About a third of patients in both groups still reported moderate to severe pain at follow-up.6Annals of Emergency Medicine. Randomized Trial of Ibuprofen Plus Baclofen, Metaxalone, or Tizanidine for Acute Low Back Pain
The trial’s conclusion was blunt: adding baclofen, metaxalone, or tizanidine to ibuprofen did not appear to improve functioning or pain any more than ibuprofen alone by one week after an emergency department visit for acute low back pain. This is a single trial, but it is a well-designed one (randomized, placebo-controlled) and its findings align with broader assessments of the combination strategy.
A critical review of the evidence on combining NSAIDs with skeletal muscle relaxants for low back pain reached a similar conclusion. While some studies reported short-term benefits in pain relief, others, particularly those reflecting real-world prescribing patterns rather than tightly controlled protocols, found no added advantage over using either drug alone. The review characterized the overall evidence as inconclusive and offering limited support for routine combination use.7The Thai Journal of Pharmaceutical Sciences. Concurrent use of skeletal muscle relaxants and NSAIDs in low back pain management: A critical review of current evidence and future directions
A separate systematic review of nonopioid treatments for acute low back pain did find that both muscle relaxants and NSAIDs were individually effective in reducing pain and disability at about one week.8PubMed. Nonopioid pharmacological management of acute low back pain: A level I of evidence systematic review The distinction matters: each drug class works on its own, but stacking them together has not been shown to reliably produce better outcomes than monotherapy. For many patients with acute low back pain, the added risk of a drug interaction may not be justified by the added benefit, which appears to be minimal at best.
Who Faces the Highest Risk
Certain groups need to be particularly cautious about combining ibuprofen with baclofen. The most obvious risk factor is any degree of existing kidney impairment. Because baclofen relies so heavily on kidney filtration for removal, even a modest further reduction in kidney function from ibuprofen can tip the balance. Clinical guidance for older adults with spine-related pain specifically recommends reducing baclofen doses in people with kidney disease.9PubMed. Pharmacotherapy for Spine-Related Pain in Older Adults
Older adults are especially vulnerable for compounding reasons. Kidney function naturally declines with age, often without any obvious symptoms or diagnosis. A 70-year-old with “normal” lab values may have meaningfully less kidney reserve than a 30-year-old. Add ibuprofen to the mix, and the margin of safety for baclofen clearance shrinks further. Dehydration, which is more common in older adults, can amplify the kidney effects of NSAIDs and push the risk even higher.
People taking higher doses of either drug face greater exposure to the interaction. Ibuprofen at prescription doses (600 to 800 mg multiple times a day) suppresses kidney prostaglandins more aggressively than the occasional over-the-counter 200 mg tablet. Similarly, higher baclofen doses leave less room for error if clearance slows. But as the case of the healthy young adult demonstrated, even lower doses can cause problems in the right circumstances, so dose alone is not a reliable safety indicator.
Other medications that affect kidney function can stack with ibuprofen to create a cumulative burden. If you are also taking an ACE inhibitor or a diuretic (water pill), for instance, adding ibuprofen creates a well-known “triple whammy” for kidney perfusion. The presence of baclofen in that mix turns a kidney-stress problem into a potential toxicity problem.
Recognizing the Signs of Baclofen Toxicity
If you are taking both drugs, knowing the warning signs of baclofen toxicity could be genuinely important. The symptoms are primarily neurological and cardiovascular. A review of published baclofen overdose cases found the most common signs were coma (occurring in over three-quarters of cases), slow heart rate (about half), hypothermia (about 40%), loss of reflexes (about 40%), muscle limpness (about 40%), and respiratory depression (about a third).10PubMed Central. Baclofen overdose mimicking anoxic encephalopathy: a case report and review of the literature These figures reflect frank overdose, but subtler versions of the same symptoms can appear when baclofen accumulates gradually due to impaired clearance.
At lower levels of toxicity, confusion, unusual drowsiness, slurred speech, and feeling “foggy” are common early warnings. The earlier case of ibuprofen-related toxicity featured confusion and disorientation as prominent symptoms.4PubMed. Baclofen toxicity associated with declining renal clearance after ibuprofen If you or someone around you notices a sudden change in mental clarity after starting this combination, or after increasing the dose of either drug, that warrants prompt medical attention.
One unusual feature of baclofen toxicity, particularly in overdose scenarios, is that cardiovascular effects can swing in both directions. A review of cases documented both low blood pressure and high blood pressure, as well as alternating fast and slow heart rates in the same patient.11BMJ Case Reports. Baclofen overdose with unique cardiovascular effects This unpredictability is part of what makes the toxicity dangerous: the presentation can mimic other emergencies, delaying correct diagnosis. The good news from the literature is that with appropriate treatment, patients who experience baclofen toxicity, even severe cases, often recover fully within about 72 hours.10PubMed Central. Baclofen overdose mimicking anoxic encephalopathy: a case report and review of the literature
Practical Considerations if You Take Both
None of this means the combination is always dangerous or that your doctor made a mistake in prescribing both. In many clinical settings, patients do take ibuprofen and baclofen together without incident. The interaction is a risk factor, not a guarantee of harm. What matters is managing that risk intelligently.
If both drugs have been prescribed for you, a few things are worth discussing with your prescriber. First, ask whether your kidney function has been checked recently. A simple blood test for creatinine gives a rough picture of how well your kidneys are filtering. If your filtration rate is already on the low side, the prescriber may want to monitor more closely or consider alternatives. Second, keep an eye on hydration. Dehydration is one of the fastest ways to worsen the kidney effects of ibuprofen, and it is easily preventable. Third, be aware of how long you are taking ibuprofen. Short courses (a few days for an acute flare) carry less cumulative kidney risk than daily use over weeks or months.
If your primary concern is acute low back pain, the randomized evidence suggests that ibuprofen on its own may be doing most of the work. Adding baclofen did not meaningfully improve disability scores or reduce pain compared to a placebo pill in the largest trial testing the question.6Annals of Emergency Medicine. Randomized Trial of Ibuprofen Plus Baclofen, Metaxalone, or Tizanidine for Acute Low Back Pain For many patients, trying ibuprofen alone first and adding baclofen only if muscle spasm is clearly a separate, uncontrolled component of the pain is a reasonable approach. Of course, baclofen is also prescribed for conditions well beyond back pain, including spasticity from multiple sclerosis, spinal cord injuries, and certain neurological disorders. In those contexts, the drug is treating a different problem entirely, and the risk-benefit calculation shifts.
Baclofen Beyond Back Pain
Baclofen’s primary clinical role is actually in managing spasticity, the involuntary muscle tightness and spasms that affect people with neurological conditions like multiple sclerosis, cerebral palsy, and spinal cord injuries. In these populations, baclofen is often taken long-term and at higher doses than what a back-pain patient would typically receive. The stakes around drug interactions are correspondingly higher because the drug is a daily fixture, not a short-term rescue.
For spinal cord injury patients in particular, baclofen’s relationship with physical rehabilitation is an active area of research. An animal study testing the combination of baclofen and ibuprofen in spinal cord injured rodents found that both drugs individually reduced pain-related responses like spasticity and writhing during hindlimb stretching exercises.12Spinal Cord. Combining clinically common drugs with hindlimb stretching in spinal cord injured rodents Interestingly, while both drugs partially mitigated stretching-related setbacks in locomotor recovery, neither fully prevented them. The research is preclinical, so direct translation to human patients is uncertain, but it suggests that even in specialized rehabilitation settings, the two drugs interact with the body in ways that are still being untangled.
People taking baclofen for spasticity management are also more likely to be on multiple other medications, including pain relievers, antispasmodics, and sometimes drugs that affect the kidneys. In that context, reaching for over-the-counter ibuprofen without thinking about the kidney interaction is a genuine hazard. Acetaminophen (Tylenol), which does not affect kidney blood flow the same way, is generally a safer over-the-counter pain option for someone on chronic baclofen, though it has its own limits and is not anti-inflammatory. The right choice depends on the specific clinical picture, which is why a conversation with a pharmacist or prescriber is worthwhile before adding anything to a baclofen regimen.